Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)

Clinical trial NCT06353334 · RECRUITING

Trial details

NCT number: NCT06353334
Sponsor: Tang Ziren
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Butylphthalide Cardiac Arrest Neuroprotective Drugs

Start date: 2021-09-01
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.